using retatrutide Retatrutide: Understanding the mechanism of action Retatrutide—A Game Changer in Obesity

The 2024 CDC numbers around national health care costs attributable to diabetes are staggering, making it the most expensive chronic condition in the U.S.: $1 out of every $4 in U.S

The FDA decision is anticipated in 4Q 2025

None of the providers can see the full treatment picture

Michael Colgan, warned decades ago that even a small drop in body water is enough to sabotage physical performanceand that is well before thirst even kicks in

If recurrent urticaria appears shortly after injections, clinicians should weigh the risks and benefits of continuing therapy

High rates of attrition (12%) were observed in Altimmunes trials, and 5% of patients on semaglutide discontinued treatment due to nausea, vomiting or diarrhea (with 25-44% of patients reporting symptoms)